Pak, Sehyung
Hwang, Sung Wook
Shim, In Kyong http://orcid.org/0000-0002-1408-9048
Bae, Sang Mun
Ryu, Yeon- Mi
Kim, Han-Byul
Do, Eun-ju
Son, Hye-Nam
Choi, Eun-ji
Park, Sun-ha
Kim, Sang-Yeob
Park, Sang Hyoung
Ye, Byong Duk http://orcid.org/0000-0001-6647-6325
Yang, Suk-Kyun
Kanai, Nobuo
Maeda, Masanori
Okano, Teruo
Yang, Dong-Hoon
Byeon, Jeong-Sik
Myung, Seung-Jae
Funding for this research was provided by:
Asan Institute for Life Sciences, Asan Medical Center (No. 2017-378, No. 2017-378, No. HI15C3078, No. 2017-378)
Korea Health Industry Development Institute (No. HI15C3078, No. HI15C3078, No. HI15C3078, No. HI15C3078, No. HI15C3078, No. HI15C3078, No. HI15C3078, No. HI15C3078)
Article History
Received: 20 October 2017
Accepted: 13 July 2018
First Online: 27 July 2018
Competing Interests
: Dr. Teruo Okano is a founder and Director of the Scientific Advisory Board of CellSeed Inc., which has licenses for certain cell sheet-related technologies and patents from Tokyo Women’s Medical University. The authors declare that there are no other financial or non-financial competing interests. Mr. Sehyung Pak, Mr. Sung Wook Hwang, Dr. In Kyong Shim, Dr. Sang Mun Bae, Dr. Yeon- Mi Ryu, Dr. Han-Byul Kim, Dr. Eun-ju Do, Dr. Hye-Nam Son, Ms. Eun-ji Choi, Ms. Sun-ha Park, Mr. Sang-Yeob Kim, Mr. Sang Hyoung Park, Dr. Byong Duk Ye, Dr. Suk-Kyun Yang, Dr. Nobuo Kanai, Dr. Masanori Maeda, Dr. Dong Hoon Yang, Dr. Jeong-Sik Byeon and Dr. Seung-Jae Myung declare no potential conflict of interest.